Please login to the form below

Not currently logged in
Email:
Password:

Cristal Therapeutics names chief medical officer

Edwin Klumper joins from contract research firm SMS-oncology 

Cristal Therapeutics, a privately-held life sciences company based in The Netherlands, has appointed Edwin Klumper as its chief medical officer.

In his new role, Klumper will be responsible for the clinical strategy and development of Cristal Therapeutics' range of nanomedicines.

He joins the pharmaceutical firm from SMS-oncology, a CRO specialising in clinical development studies in oncology, which he co-founded in 2007.

Klumper served as its chief medical officer until 2013 when he became the organisation's interim chief executive.

Prior to this, Klumper served as vice president, marketing and sales Europe at Nabi Biopharmaceuticals and business unit director for The Netherlands at Amgen.

He also brings experience from ASTA Medica and start-up Yew Tree Pharmaceuticals where he served as its medical director.

Joost Holthuis, Cristal Therapeutics' chief executive officer, said: “We are extremely fortunate to have Edwin joining our leadership team.

“Edwin will no doubt contribute to the already firm nanomedicine programme of CriPec docetaxel, as well as help up move forward in our efforts to develop novel proprietary nanomedicines.”

4th May 2016

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....